Goldman Sachs’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.87M | Buy |
|
|||||
|
2025
Q1 | $1.16M | Sell |
|
|||||
|
2024
Q4 | $2.55M | Sell |
|
|||||
|
2024
Q3 | $3.31M | Buy |
|
|||||
|
2024
Q2 | $3.48M | Sell |
|
|||||
|
2024
Q1 | $7.65M | Sell |
|
|||||
|
2023
Q4 | $5.88M | Buy |
|
|||||
|
2023
Q3 | $1.15M | Sell |
|
|||||
|
2023
Q2 | $1.28M | Buy |
|
|||||
|
2023
Q1 | $849K | Sell |
|
|||||
|
2022
Q4 | $2.3M | Sell |
|
|||||
|
2022
Q3 | $2.79M | Buy |
|
|||||
|
2022
Q2 | $1.39M | Buy |
|
|||||
|
2022
Q1 | $5.62M | Buy |
|
|||||
|
2021
Q4 | $1.5M | Buy |
|
|||||
|
2021
Q3 | $1.76M | Buy |
|
|||||
|
2021
Q2 | $288K | Buy |
|
|||||
|
2021
Q1 | $169K | Sell |
|
|||||
|
2020
Q4 | $174K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $185K | Buy |
|